AIDS vaccine HIV vaccine. Funding unclear and side effects. Why continue? Question to the ministers
In 2003, the National Institute of Health (ISS) decided to experiment with a human AIDS vaccine based on recombinant HIV-1 TAT.
In 2005, the Italian Drug Agency (AIFA) in charge of the inspection performed on clinical trials, claimed to have found seven critical deviations and 3 major deviations, all the responsibility of the sponsor, namely the ISS. The minutes
AIFA informed that the trial had not reached their goals and the risks in continuing it. The
dott.sa Ensoli, going against the statement by the AIFA, argued instead that the objectives of the trial had been achieved and that it would just go ahead with the trial. To authorize this, the ISS 'to move to Phase II trials in South Africa.
On November 22, 2007 an article in the weekly L'Express reported that according to the discoverer of the AIDS virus, Robert Gallo, the active Tat used by the ISS is potentially toxic. In addition, the article reports that the trial results were never published in a major international scientific journal and that would have occurred very serious side effects such as a case of paresis facial muscle and another important issue.
Funding: According to various sources, including the prestigious scientific journal Science (vol. 317, 10 August 2007): all were from the Italian government allocated 52 million euro, of which 21 are from the Ministry of Health 'for experimentation in Italy and 31 for a comprehensive program against AIDS in South Africa. Neither of the two funds and 'was submitted to the system of "peer review" that provides for the evaluation of projects by the referees / anonymous reviewers, competent in matters of scientific and independent project by the proposer of the project. Replication and 'arrived on 18 November: Enrico Garaci, president of ISS, the pages of the newspaper IlSole24Ore, recalled how the money allocated so far to advance the phase II vaccine trials in Italy and South Africa are 37 million and € 52.
What are the reasons why such testing is being carried out by even more 'parts if they're exposed the danger'. For more details visit
http://www.lucacoscioni.it/vaccino
0 comments:
Post a Comment